{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:41Z","timestamp":1786982201446,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Centre Egypt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Lysosomal acid lipase (LAL) is a necessary enzyme for the hydrolysis of both triglycerides (TGs) and cholesteryl esters (CEs) in the lysosome. Deficiency of this enzyme encoded by the lipase A (\n                    <jats:italic>LIPA<\/jats:italic>\n                    ) gene leads to LAL deficiency (LAL-D). A severe disease subtype of LAL-D is known as Wolman disease (WD), present with diarrhea, hepatosplenomegaly, and adrenal calcification. Untreated patients do not survive more than a year. The aim of this study was to assess the clinical and molecular characterizations of WD patients in Egypt. A total of seven patients (from five unrelated Egyptian families) were screened by targeted next-generation sequencing (NGS), and the co-segregation of causative variants was analyzed using Sanger sequencing. Furthermore, multiple in silico analyses were performed to assess the pathogenicity of the candidate variants. Overall, we identified three diseases causing variants harbored in the\n                    <jats:italic>LIPA<\/jats:italic>\n                    gene. One of these variants is a novel missense variant (NM_000235.4: c.1122\u00a0T\u2009&gt;\u2009G; p. His374Gln), which was classified as a likely pathogenic variant. All variants were predicted to be disease causing using in silico analyses. Our findings expand the spectrum of variants involved in WD which may help to investigate phenotype-genotype correlation and assist genetic counseling. To the best of our knowledge, this is the first clinico-genetic study carried out on Egyptian patients affected with WD.\n                  <\/jats:p>","DOI":"10.1007\/s12031-023-02139-6","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T10:12:46Z","timestamp":1689847966000},"page":"598-607","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["First LIPA Mutational Analysis in Egyptian Patients Reveals One Novel Variant: Wolman Disease"],"prefix":"10.1007","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5872-9134","authenticated-orcid":false,"given":"Nesma M.","family":"Elaraby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Reda","family":"Galal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abdel-Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasnaa M.","family":"Elbendary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elbadry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona K.","family":"Mekkawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neveen A.","family":"Ashaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir M.","family":"Mounir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engy A.","family":"Ashaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"issue":"3","key":"2139_CR1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1001\/archpedi.1956.02060020284010","volume":"91","author":"A Abramov","year":"1956","unstructured":"Abramov A, Schorr S, Wolman M (1956) Generalized xanthomatosis with calcified adrenals. AMA J Dis Child 91(3):282\u2013286. https:\/\/doi.org\/10.1001\/archpedi.1956.02060020284010","journal-title":"AMA J Dis Child"},{"key":"2139_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12887-021-02541-2","volume":"21","author":"F Alabbas","year":"2021","unstructured":"Alabbas F, Elyamany G, Alanzi T et al (2021) Wolman\u2019s disease presenting with secondary hemophagocytic lymphohistiocytosis: a case report from Saudi Arabia and literature review. BMC Pediatr 21:72. https:\/\/doi.org\/10.1186\/s12887-021-02541-2","journal-title":"BMC Pediatr"},{"issue":"6","key":"2139_CR3","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.jhep.2013.02.014","volume":"58","author":"DL Bernstein","year":"2013","unstructured":"Bernstein DL, Hulkova H, Bialer MG, Desnick RJ (2013) Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease. J Hepatol 58(6):1230\u20131243","journal-title":"J Hepatol"},{"issue":"1","key":"2139_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jhep.2018.09.028","volume":"70","author":"A Carter","year":"2019","unstructured":"Carter A, Brackley SM, Gao J, Mann JP (2019) The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: a rare condition that mimics NAFLD. J Hepatol 70(1):142\u2013150","journal-title":"J Hepatol"},{"issue":"3","key":"2139_CR5","first-page":"150","volume":"9","author":"M\u015e Cansever","year":"2019","unstructured":"Cansever M\u015e, Aslan M, Z\u00fcbario\u011flu T (2019) A New Mutation in Diagnosis of Wolman Disease: Case Report JAREM 9(3):150\u2013152","journal-title":"A New Mutation in Diagnosis of Wolman Disease: Case Report JAREM"},{"key":"2139_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.aohep.2018.07.005","volume":"18","author":"A Consuelo-S\u00e1nchez","year":"2019","unstructured":"Consuelo-S\u00e1nchez A, V\u00e1zquez-Frias R, Reyes-De La Rosa A, Acosta-Rodr\u00edguez-Bueno CP, Ortal-Vite MP, Cebolla JJ (2019) Mutations identified in a cohort of Mexican patients with lysosomal acid lipase deficiency. Ann Hepatol 18:646\u2013650. https:\/\/doi.org\/10.1016\/j.aohep.2018.07.005","journal-title":"Ann Hepatol"},{"key":"2139_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/humu.23837","volume":"6","author":"G Del Angel","year":"2019","unstructured":"Del Angel G, Hutchinson AT, Jain NK, Forbes CD, Reynders J (2019) Large-scale functional LIPA variant characterization to improve birth prevalence estimates of lysosomal acid lipase deficiency. Hum Mutat 6:66. https:\/\/doi.org\/10.1002\/humu.23837","journal-title":"Hum Mutat"},{"key":"2139_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.tips.2018.12.006","volume":"40","author":"M Gomaraschi","year":"2019","unstructured":"Gomaraschi M, Bonacina F, Norata GD (2019) Lysosomal acid lipase: from cellular lipid handler to immunometabolic target. Trends Pharmaco Sci 40:104\u2013115. https:\/\/doi.org\/10.1016\/j.tips.2018.12.006","journal-title":"Trends Pharmaco Sci"},{"key":"2139_CR9","unstructured":"Grabowski G, Charnas L, Du H (2021) Lysosomal acid lipase deficiencies: the Wolman disease\/cholesterol ester storage disease spectrum. The Online Metabolic & Molecular Bases of Inherited Disease. http:\/\/www.ommbid.com\/OMMBID\/a\/c.html\/lysosomal_disorders\/acid_lipase_deficiency_wolman_disease_cholesteryl_ester_storage_disease"},{"key":"2139_CR10","first-page":"1","volume-title":"GeneReviews","author":"EP Hoffman","year":"2016","unstructured":"Hoffman EP, Barr ML, Giovanni MA, Murray MF (2016) Lysosomal acid lipase deficiency. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K et al (eds) GeneReviews. University of Washington; Updated, Seattle, p 1"},{"key":"2139_CR11","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cca.2012.03.019","volume":"413","author":"J Hamilton","year":"2012","unstructured":"Hamilton J, Jones I, Srivastava R, Galloway P (2012) A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2. Clin Chim Acta 413:1207\u20131210. https:\/\/doi.org\/10.1016\/j.cca.2012.03.019","journal-title":"Clin Chim Acta"},{"key":"2139_CR12","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/gim.2015.108","volume":"18","author":"SA Jones","year":"2016","unstructured":"Jones SA, Valayannopoulos V, Schneider E, Eckert S, Banikazem M, Bialer M, Cederbaum S, Chan A, Dhawan A, Di Rocco M et al (2016) Rapid progression and mortality of lysosomal acid lipase deficiency presenting in infants. Genet Med 18:452\u2013458. https:\/\/doi.org\/10.1038\/gim.2015.108","journal-title":"Genet Med"},{"key":"2139_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13023-017-0587-3","volume":"12","author":"SA Jones","year":"2017","unstructured":"Jones SA, Rojas-Caro S, Quinn AG, Friedman M, Marulkar S, Ezgu F, Zaki O, Gargus JJ, Hughes J, Plantaz D et al (2017) Survival in infants treated with sebelipase alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study. Orphanet J Rare Dis 12:25. https:\/\/doi.org\/10.1186\/s13023-017-0587-3","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"2139_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27929","volume":"66","author":"MB Jordan","year":"2019","unstructured":"Jordan MB, Allen CE, Greenberg J, Henry M, Hermiston ML, Kumar A et al (2019) Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: recommendations from the North American Consortium for Histiocytosis (NACHO). Pediatr Blood Cancer 66(11):e27929","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"2139_CR15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.31584\/jhsmr.2021803","volume":"39","author":"P Koranantakul","year":"2021","unstructured":"Koranantakul P, Tim-Aroon T, Jaruratanasirikul S (2021) Wolman disease with a low cholesterol level: an unusual laboratory finding. J Health Sci Med Res 39(6):517\u2013522. https:\/\/doi.org\/10.31584\/jhsmr.2021803","journal-title":"J Health Sci Med Res"},{"key":"2139_CR16","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1161\/ATVBAHA.119.312136","volume":"39","author":"F Li","year":"2019","unstructured":"Li F, Zhang H (2019) Lysosomal acid lipase in lipid metabolism and beyond. Arter Thromb Vasc Biol 39:850\u2013856. https:\/\/doi.org\/10.1161\/ATVBAHA.119.312136","journal-title":"Arter Thromb Vasc Biol"},{"key":"2139_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cradex.2004.05.002","volume":"59","author":"G Low","year":"2004","unstructured":"Low G, Irwin G, MacPhee G, Robinson P (2004) Characteristic imaging findings in Wolman\u2019s disease. Clin Radiol Extra 59:106\u2013108. https:\/\/doi.org\/10.1016\/j.cradex.2004.05.002","journal-title":"Clin Radiol Extra"},{"key":"2139_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2018.02.023","volume":"481","author":"F Louillet","year":"2018","unstructured":"Louillet F, Broux F, Charbonnier F, Dranguet H, Coutant S, Vezain M, Lanos R, Tebani A, Fuller M, Lamar F et al (2018) Metabolic causes of nonimmune hydrops fetalis: a next-generation sequencing panel as a first-line investigation. Clin Chim Acta 481:1\u20138. https:\/\/doi.org\/10.1016\/j.cca.2018.02.023","journal-title":"Clin Chim Acta"},{"key":"2139_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s40256-017-0228-1","volume":"17","author":"JJ Maciejko","year":"2017","unstructured":"Maciejko JJ (2017) Managing cardiovascular risk in lysosomal acid lipase deficiency. Am J Cardiovasc Drugs 17:217\u2013231. https:\/\/doi.org\/10.1007\/s40256-017-0228-1","journal-title":"Am J Cardiovasc Drugs"},{"key":"2139_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4236\/ajmb.2017.74013","volume":"7","author":"A Mandadzhieva","year":"2017","unstructured":"Mandadzhieva A, Avdzhieva-Tzavella D, Todorov T, Tincheva S et al (2017) Wolman disease in Bulgarian patients: selective genetic screening in two presumable endemic regions. Am J Mol Biol 7:169\u2013175. https:\/\/doi.org\/10.4236\/ajmb.2017.74013","journal-title":"Am J Mol Biol"},{"key":"2139_CR21","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s12031-019-01376-y","volume":"69","author":"N Parsamanesh","year":"2019","unstructured":"Parsamanesh N, Safarpour H, Etesam S, Shadmehri AA, Miri-Moghaddam E (2019) Identification and in silico characterization of a novel point mutation within the phosphatidylinositol glycan anchor biosynthesis class G gene in an Iranian family with intellectual disability. J Mol Neurosci 69:538\u2013545. https:\/\/doi.org\/10.1007\/s12031-019-01376-y","journal-title":"J Mol Neurosci"},{"key":"2139_CR22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2147\/DDDT.S149264","volume":"14","author":"GM Pastores","year":"2020","unstructured":"Pastores GM, Hughes DA (2020) Lysosomal acid lipase deficiency: therapeutic options. Drug Des Dev Ther 14:591\u2013601. https:\/\/doi.org\/10.2147\/DDDT.S149264","journal-title":"Drug Des Dev Ther"},{"key":"2139_CR23","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S2468-1253(17)30052-3","volume":"2","author":"M Pericleous","year":"2017","unstructured":"Pericleous M, Kelly C, Wang T, Livingstone C, Ala A (2017) Wolman\u2019s disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency. Lancet Gastroenterol Hepatol 2:670\u2013679. https:\/\/doi.org\/10.1016\/S2468-1253(17)30052-3","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2139_CR24","doi-asserted-by":"publisher","unstructured":"Parham JS, Underberg JA (2021) Lysosomal acid lipase deficiency. Therap Lipidol 405. https:\/\/doi.org\/10.1007\/978-3-030-56514-5_21","DOI":"10.1007\/978-3-030-56514-5_21"},{"issue":"5198","key":"2139_CR25","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/2221067a0","volume":"222","author":"AD Patrick","year":"1969","unstructured":"Patrick AD, Lake BD (1969) Deficiency of an acid lipase in Wolman\u2019s disease. Nature 222(5198):1067\u20131068","journal-title":"Nature"},{"key":"2139_CR26","doi-asserted-by":"publisher","unstructured":"Pagani F, Garcia R, Pariyarath R, Stuani C, Gridelli B, Paone G, Baralle F (1996) Espression of lysosomal acid lipase mutants detected in three patients with cholesteryl ester storage disease. Human Mole Gene 1611\u20131617. https:\/\/doi.org\/10.1093\/hmg\/5.10.1611","DOI":"10.1093\/hmg\/5.10.1611"},{"key":"2139_CR27","doi-asserted-by":"publisher","unstructured":"Pagani F, Pariyarath R, Garcia R, Stuani C, Burlina A, Ruotolo G, Rabusin M, Baralle F (1998) New lysosomal acid lipase gene mutants explain the phenotype of wolman disease and cholesteryl ester storage disease. J Lipid Res (39):1382\u20131388. https:\/\/doi.org\/10.1016\/S0022-2275(20)32518-9","DOI":"10.1016\/S0022-2275(20)32518-9"},{"key":"2139_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13023-021-01849-7","volume":"16","author":"JE Potter","year":"2021","unstructured":"Potter JE, Petts G, Ghosh A, White FJ, Kinsella JL, Hughes S, Roberts J, Hodgkinson A, Brammeier K, Church H et al (2021) Enzyme replacement therapy and hematopoietic stem cell transplant: A new paradigm of treatment in Wolman disease. Orphanet J Rare Dis 16:235. https:\/\/doi.org\/10.1186\/s13023-021-01849-7","journal-title":"Orphanet J Rare Dis"},{"key":"2139_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2014.04.003","volume":"235","author":"Z Reiner","year":"2014","unstructured":"Reiner Z, Guardamagna O, Nair D, Soran H, Hovingh K, Bertolini S, Jones S, Coric M, Calandra S, Hamilton J, Eagleton T, Ros E (2014) Lysosomal acid lipase deficiency\u2014an under recognized cause of dyslipidaemia and liver dysfunction. Atherosclerosis 235:21\u201330. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.04.003","journal-title":"Atherosclerosis"},{"key":"2139_CR30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das D et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"2139_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/8904_2017_6","volume":"37","author":"C Ruiz-Andr\u00e9s","year":"2017","unstructured":"Ruiz-Andr\u00e9s C, Sell\u00e9s E, Arias A, Gort L (2017) Lysosomal Acid Lipase Deficiency in 23 Spanish Patients: High Frequency of the Novel c.966+2T>G Mutation in Wolman Disease. JIMD Rep 37:7\u201312. https:\/\/doi.org\/10.1007\/8904_2017_6","journal-title":"JIMD Rep"},{"key":"2139_CR32","doi-asserted-by":"publisher","unstructured":"Strebinger G, M\u00fcller E, Feldman A, Aigner E\u00a0(2019) Lysosomal acid lipase deficiency early diagnosis is the key. Hepatic Medicine 23(11):79\u201388. https:\/\/doi.org\/10.2147\/HMER.S201630","DOI":"10.2147\/HMER.S201630"},{"issue":"5","key":"2139_CR33","first-page":"597","volume":"23","author":"DK Shome","year":"2002","unstructured":"Shome DK, Al-Jishi E, Greally JF, Malik N, Zainaldeen HA, Das NS (2002) The Middle-East connection of Wolman Disease. Saudi Med J 23(5):597\u2013601","journal-title":"Saudi Med J"},{"key":"2139_CR34","doi-asserted-by":"publisher","unstructured":"Shenoy P, Karegowda L, Sripathi S, Mohammed N (2014) Wolman disease in an infant. In: BMJ Case Reports.\u00a0https:\/\/doi.org\/10.1136\/bcr-2014-203656","DOI":"10.1136\/bcr-2014-203656"},{"key":"2139_CR36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cca.2021.04.005","volume":"519","author":"A Tebani","year":"2021","unstructured":"Tebani A, B\u00b4en\u00b4edicte Sudri\u00b4e-Arnaud, Hela Boudabous, Anais Brassier, Rodolphe Anty, Sarah Snanoudj, Armand Abergel, Marie-Th\u00b4er`ese Abi Warde, Edouard Bardou-Jacquet et al (2021) Large-scale screening of lipase acid deficiency in at risk population. Clin Chim Acta 519:64\u201369. https:\/\/doi.org\/10.1016\/j.cca.2021.04.005","journal-title":"Clin Chim Acta"},{"key":"2139_CR37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1089\/gtmb.2010.0203","volume":"15","author":"Y Valles-Ayoub","year":"2011","unstructured":"Valles-Ayoub Y, Esfandiarifard S, Sinai P, Khokher Z, Kohan M, Kahen T, Darvish D (2011) Wolman Disease (LIPA p. G87V) Genotype Frequency in People of Iranian-Jewish Ancestry. Genet Test Mol Biomarkers 15:395\u2013398. https:\/\/doi.org\/10.1089\/gtmb.2010.0203","journal-title":"Genet Test Mol Biomarkers"},{"key":"2139_CR38","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0022-2275(20)31591-1","volume":"42","author":"O Zschenker","year":"2001","unstructured":"Zschenker O, Jung N, Rethmeier J, Trautwein S, Hertel S, Zeigler M, Ameis D (2001) Characterization of Lysosomal Acid Lipase Mutations in the Signal Peptide and Mature Polypeptide Region Causing Wolman Disease. J Lipid Res 42:1033\u20131040. https:\/\/doi.org\/10.1016\/S0022-2275(20)31591-1","journal-title":"J Lipid Res"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-023-02139-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-023-02139-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-023-02139-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T14:09:00Z","timestamp":1695391740000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-023-02139-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":37,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["2139"],"URL":"https:\/\/doi.org\/10.1007\/s12031-023-02139-6","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]},"assertion":[{"value":"16 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. This study has been approved by the Medical Research Ethics Committee of the National Research Centre (NRC), Cairo, Egypt (ID: 74712012021). Written informed consent was obtained from parents following a full explanation of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}